Last reviewed · How we verify
EVICEL Fibrin Sealant
At a glance
| Generic name | EVICEL Fibrin Sealant |
|---|---|
| Also known as | Fibrin sealant, EVICEL, fibrin sealant, fibrin sealant |
| Sponsor | Ethicon, Inc. |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Paediatric EVICEL® Neuro Study (PHASE3)
- Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function (NA)
- A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants (PHASE3)
- The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study (PHASE3)
- A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICEL™ Fibrin Sealant in Thyroidectomy (NA)
- The EVICEL® Neurosurgery Phase III Study (PHASE3)
- Fistulodesis Pilot Study for Closure of Perianal Fistulae (NA)
- Prevention of Postoperative Bleeding in Subcapital Femoral Fractures (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EVICEL Fibrin Sealant CI brief — competitive landscape report
- EVICEL Fibrin Sealant updates RSS · CI watch RSS
- Ethicon, Inc. portfolio CI